MedPath

Clinical study on glycemic excursion improvements with a DPP-4 inhibitor and a glinide in patients with type 2 diabetic mellitus - a comparative efficacy analysis using continuous glucose monitoring (CGM)

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000009525
Lead Sponsor
aka Kinen Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients to whom [Contraindications] in labeling for the experimental drugs (sitagliptin and mitiglinide formulations or sitagliptin / mitiglinide combinations) apply 2)Any others who the principal investigator deems unsuitable as subjects, in consideration of any [Special caution needed] in labeling for the experimental drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath